论文部分内容阅读
德国Schnabel等的研究结果显示,影响晚期非小细胞肺癌(NSCLC)患者临床常规一线治疗决策的关键因素包括组织学、体能状态和年龄等。FRAME是前瞻性观察性研究,旨在对NSCLC患者一线治疗进行评估。中期分析探讨组织学和生物标志物对治疗决策的影响。
According to a study by Schnabel et al. In Germany, the key determinants of first-line, routine clinical decision-making in patients with advanced non-small cell lung cancer (NSCLC) include histology, fitness status, and age. FRAME is a prospective observational study designed to assess first-line treatment of NSCLC patients. Interim analysis explores the impact of histology and biomarkers on treatment decisions.